NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NLRP3 promotes immune escape by regulating immune checkpoints: A pan-cancer analysis
Authors
Keywords
NLRP3, Immune escape, Immune checkpoints, Microsatellite instability, Tumor mutational burden
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 104, Issue -, Pages 108512
Publisher
Elsevier BV
Online
2022-01-11
DOI
10.1016/j.intimp.2021.108512
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting cancer-promoting inflammation — have anti-inflammatory therapies come of age?
- (2021) Jiajie Hou et al. Nature Reviews Clinical Oncology
- NLRP3 inflammasome in cancer and metabolic diseases
- (2021) Bhesh Raj Sharma et al. NATURE IMMUNOLOGY
- Genomic and immunological features of microsatellite instability in colon cancer
- (2021) Yi Luo et al. GENE
- Predictive biomarkers for response to immune checkpoint inhibition
- (2021) Benjamin Shum et al. SEMINARS IN CANCER BIOLOGY
- BAFF-driven NLRP3 inflammasome activation in B cells
- (2020) Ken-Hong Lim et al. Cell Death & Disease
- NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma
- (2020) Fei Lu et al. CANCER LETTERS
- Potential Interplay between Dietary Saturated Fats and Genetic Variants of the NLRP3 Inflammasome to Modulate Insulin Resistance and Diabetes Risk: Insights from a Meta‐Analysis of 19 005 Individuals
- (2019) Aoife M. Murphy et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma
- (2019) Qi-Feng Chen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses
- (2019) Huimin Dan et al. OncoTargets and Therapy
- Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
- (2018) Thitinee Vanichapol et al. Biomed Research International
- NLRP3 inflammasome: Its regulation and involvement in atherosclerosis
- (2017) Zahra Hoseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cancer cells induce interleukin-22 production from memory CD4+T cells via interleukin-1 to promote tumor growth
- (2017) Cornelia Voigt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Canonical Stimulation of the NLRP3 Inflammasome by Fungal Antigens Links Innate and Adaptive B-Lymphocyte Responses by Modulating IL-1β and IgM Production
- (2017) Mohamed F. Ali et al. Frontiers in Immunology
- Genome-wide association analysis identifies genetic correlates of immune infiltrates in solid tumors
- (2017) Nathan O. Siemers et al. PLoS One
- Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
- (2016) Scott J Antonia et al. LANCET ONCOLOGY
- The Nlrp3 Inflammasome Suppresses Colorectal Cancer Metastatic Growth in the Liver by Promoting Natural Killer Cell Tumoricidal Activity
- (2015) Jeremy Dupaul-Chicoine et al. IMMUNITY
- Mechanism of NLRP3 inflammasome activation
- (2014) Fayyaz S. Sutterwala et al. Annals of the New York Academy of Sciences
- Clinical significance of microsatellite instability for stage II or III colorectal cancer following adjuvant therapy with doxifluridine
- (2010) Byung Woog Kang et al. MEDICAL ONCOLOGY
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
- (2010) Myunggon Ko et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started